Clinical Trials Sponsored by Institute for Cardiometabolic Diseases, Karl Landsteiner Society
Total 1 results
-
Wilhelminenspital ViennaAssociation for the Promotion of Research in Atherosclerosis, Thrombosis... and other collaboratorsCompleted
Sponsors and Collaborators
- Kuwait University
- Sahar Salehi
- Xiao-Ming Mao
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Only For Children Pharmaceuticals
- Royal Hobart Hospital Research Foundation (funding source)
- Jia Liu
- Egyptian Russian University
- Kerstyn C. Zalesin, M.D.
- Friedrich Miescher Institute for Biomedical Research (FMI)
- Hopeful Aging
- Klinikum Bad Woerishofen
- Van Boven, Robert W., M.D.
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Liming Cheng
- Hoersholm Hospital
- Marcus Vinícius Guimarães de Lacerda
- Pancreatic Cancer UK
- Genuv Inc.
- The People's Hospital of Guangxi Zhang Autonomous Region
- View Full List
Medical Conditions
- Advanced Gastric Cancer With Serosal Invasion
- Enlarged Uterus
- Pancytopenia Due to Chemotherapy
- Autologous Haematopoietic Stem Cell Transplant
- Pulmonary Invasive Aspergillosis
- Stage II Vulvar Cancer
- High Perinatal Mortality
- Stereotype-threat
- Global Health
- Smith-Lemli-Opitz Syndrome
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- EHMT1
- Role of Vitamin D in IVF for Better Outcome
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- Airway Obstruction
- Raynaud Secondary to Other Autoimmune Disease
- Gait Variability; Elders; Fall; Re-education
- Caffeine Dosage
- Urinary Tract Carcinoma
- Secondary Hypertension to Endocrine Disorders
- View Full List
Drug Interventions
- LX4211 800 mg
- Androgen-deprivation Therapy (ADT)
- Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
- Ibudilast
- RDEA3170 12 mg
- Vehicle Foam with UVA and UVB and visible light irradiation
- Jatenzo
- MC-1101
- CAZ/AVI plus Aztreonam
- P276-00
- Nystatin
- APD334
- ACP-204
- High-dose loop diuretics
- Omalizumab Injection
- Naltrexone and bupropion SR
- Iohexol Inj 300 MG/ML
- Ustekinumab
- IBI318
- Olopatadine hydrochloride ophthalmic solution 0.7%)
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Belarus
- Contract Research Organizations in Canada
- Contract Research Organizations in Hungary
- Contract Research Organizations in Jordan
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Russia
- Contract Research Organizations in South Africa
- Contract Research Organizations in Suriname
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Uganda
- CRO list by country